# Zynerba Pharmeceuticals, Inc. — Form D

Zynerba Pharmeceuticals, Inc. of Radnor, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-09. The offering totals $13.0M, of which $7.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-10-09
- Form: D
- Accession: 0001621443-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $7.3M
- Remaining: $5.7M
- Investors: 30
- Date of first sale: 2014-09-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-226158

## Issuer

- Name: Zynerba Pharmeceuticals, Inc.
- CIK: 0001621443
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 170 N. Radnor-Chester Road, Radnor, PA, 19087
- Phone: 610-263-0163

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Armando Anindo | Director | Radnor, PA |
| Steven Gailar | Director | Radnor, PA |
| Philip Wagenheim | Director | Austin, TX |
| Armando Anindo | Executive Officer | Radnor, PA |
| Suzanne B Hanlon | Executive Officer | Radnor, PA |
| Terri B Sebree | Executive Officer | Radnor, PA |

## More

- [CIK 1621443 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1621443&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001621443-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.